Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zobofit is a multi-component herbal dietary supplement developed by NutriMed Group, specifically designed to support and normalize the functional state of the thyroid gland. The formulation is centered around the extract of *Potentilla alba* (White Cinquefoil), which is rich in elemental iodine, tannins, and flavonoids, and is traditionally recognized for its thyrotropic and anti-inflammatory properties. Complementary ingredients include extracts of birch leaves (*Betula pendula*), meadowsweet (*Filipendula ulmaria*), hazel (*Corylus avellana*), peony root (*Paeonia anomala*), and chickweed (*Stellaria media*). These components work synergistically to provide antioxidant protection, reduce inflammation in thyroid tissue, and assist in the regulation of thyroid hormone production. Zobofit is primarily utilized in the management of autoimmune thyroiditis, endemic goiter, and both hyper- and hypothyroidism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zobofit.